Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tommysdad who wrote (3240)	12/8/1997 9:53:00 PM
From: Peter Silsbee	of 6136

I agree. Someone had suggested the Thymitaq outlicense as a possibility earlier. Just checking... Some of the language in at least one recent article has implied that they are actively seeking in-licensing opportunities, but I haven't seen any direct quotes from AGPH to this effect. PLS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next